Regulatory Milestone Validates JBA AI’s Clinical-Grade Software for Advanced Diagnostic Support

A Medtronic (NYSE: MDT)+
official announced on social media that the company received CE mark for its VitalFlow system within its Cardiac Surgery portfolio.